Cargando…

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients

BACKGROUND: It is not known which risk stratification system has the best discrimination ability for predicting prostate cancer death. METHODS: We identified patients with non-metastatic primary prostate adenocarcinoma diagnosis between 2004 and 2015 using the Surveillance, Epidemiology, and End Res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Mu, Gao, Xian-Shu, Ma, Ming-Wei, Gu, Xiao-Bin, Li, Hong-Zhen, Lyu, Feng, Bai, Yun, Chen, Jia-Yan, Ren, Xue-Ying, Liu, Ming-Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076565/ https://www.ncbi.nlm.nih.gov/pubmed/33928035 http://dx.doi.org/10.3389/fonc.2021.646073

Ejemplares similares

Comparison of Different Risk-Stratification Systems for the Diagnosis of Benign and Malignant Thyroid Nodules
por: Shen, Yan, et al.
Publicado: (2019)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy
por: Liu, Peilin, et al.
Publicado: (2021)

Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research
por: Lyu, Feng, et al.
Publicado: (2023)

Contouring lumbosacral plexus nerves with MR neurography and MR/CT deformable registration technique
por: Cao, Xi, et al.
Publicado: (2022)

Biomarkers for Prostate Cancer: From Diagnosis to Treatment
por: Chen, Jia-Yan, et al.
Publicado: (2023)

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients
por: Ma, Ming-Wei, et al.
Publicado: (2020)

Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
por: Wang, Zhuonan, et al.
Publicado: (2022)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer
por: Basourakos, Spyridon P., et al.
Publicado: (2021)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Establishment of an Ultrasound Malignancy Risk Stratification Model for Thyroid Nodules Larger Than 4 cm
por: Xi, Xuehua, et al.
Publicado: (2021)

(18)F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer
por: Wang, Zhuonan, et al.
Publicado: (2021)

Efficacy of Hepatic Resection vs. Radiofrequency Ablation for Patients With Very-Early-Stage or Early-Stage Hepatocellular Carcinoma: A Population-Based Study With Stratification by Age and Tumor Size
por: Jiang, Yi-Quan, et al.
Publicado: (2019)

Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
por: Xu, Jinye, et al.
Publicado: (2022)

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016)

Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size
por: Feng, Jia-Wei, et al.
Publicado: (2022)

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
por: Tang, Lirui, et al.
Publicado: (2022)

Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
por: Zhang, Yang, et al.
Publicado: (2023)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
por: Bin, Xu, et al.
Publicado: (2020)

Establishment of an Individualized Predictive Model to Reduce the Core Number for Systematic Prostate Biopsy: A Dual Center Study Based on Stratification of the Disease Risk Score
por: Chen, Zeyu, et al.
Publicado: (2022)

A comprehensive comparative assessment of eight risk stratification systems for thyroid nodules in the elderly population
por: Ma, Xiao, et al.
Publicado: (2023)

SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer
por: Zhao, Ying-Ying, et al.
Publicado: (2022)

(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
por: Dong, Siying, et al.
Publicado: (2022)

Oncological Outcomes of Adjuvant Radiotherapy for Partial Ureterectomy in Distal Ureteral Urothelial Carcinoma Patients
por: Li, Hong-zhen, et al.
Publicado: (2021)

Towards an Improved Pathological Node Classification for Prognostic Stratification of Patients With Oral Cavity Squamous Cell Carcinoma: Results From a Nationwide Registry Study
por: Kang, Chung-Jan, et al.
Publicado: (2022)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

A Novel MRI-Based Risk Stratification Algorithm for Predicting Postoperative Recurrence of Meningioma: More Benefits to Patients
por: Zhang, Rufei, et al.
Publicado: (2021)

Identification of Metabolism-Related Gene-Based Subgroup in Prostate Cancer
por: Yu, Guopeng, et al.
Publicado: (2022)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
por: Huang, Junting, et al.
Publicado: (2020)

Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity‐modulated proton therapy
por: Ren, Xue‐Ying, et al.
Publicado: (2021)

Association of Caveolin-1 Expression With Prostate Cancer: A Systematic Review and Meta-Analysis
por: Chen, Pei, et al.
Publicado: (2021)

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer
por: Cui, Ming, et al.
Publicado: (2017)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

A Comprehensive Risk Assessment and Stratification Model of Papillary Thyroid Carcinoma Based on the Autophagy-Related LncRNAs
por: Mu, Yongrun, et al.
Publicado: (2022)

Derivation and Validation of a Prognostic Scoring Model Based on Clinical and Pathological Features for Risk Stratification in Oral Squamous Cell Carcinoma Patients: A Retrospective Multicenter Study
por: Zhou, Jiaying, et al.
Publicado: (2021)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
por: Guo, Xiao-Xiao, et al.
Publicado: (2021)

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters
por: Sharova, Evgeniya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ne0pt6tearg6e1i6cprp95b30u